Sleep in rheumatic diseases and other painful conditions

Current Treatment Options in Neurology

Volumn 9, Issue 5, 2007, Pages 325-336

  Buenaver, Luis F ^a   Smith, Michael T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ADRENALIN; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORPROMAZINE; DOPAMINE; ESZOPICLONE; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; MELATONIN; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; NORTRIPTYLINE; OLANZAPINE; RAMELTEON; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM TARTRATE;

ALCOHOLIC BEVERAGE; ALERTNESS; AMNESIA; ANOREXIA; ANTICHOLINERGIC SYNDROME; ANXIETY DISORDER; ATRIOVENTRICULAR BLOCK; BALANCE DISORDER; BEHAVIOR DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; COORDINATION DISORDER; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG ALCOHOL INTERACTION; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FALLING; FATIGUE; FIBROMYALGIA; FOOD DRUG INTERACTION; HEALTH CARE COST; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; INSOMNIA; KINESIOTHERAPY; LIPID DIET; LOW DRUG DOSE; MANIA; MONOTHERAPY; MOTOR DYSFUNCTION; MUSCLE SPASM; NAUSEA; NERVOUSNESS; OPTIMAL DRUG DOSE; ORTHOSTATIC HYPOTENSION; OSTEOARTHRITIS; PARASOMNIA; PATIENT EDUCATION; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; RECOMMENDED DRUG DOSE; RELAXATION TRAINING; RESTLESS LEGS SYNDROME; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEDATION; SEXUAL FUNCTION; SIDE EFFECT; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SLEEP WALKING; SWEATING; TACHYCARDIA; THOUGHT DISORDER; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 34548483172     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02938539     Document Type: Review

References (69)

1. Siegel JM: Clues to the functions of mammalian sleep. Nature 2005, 437:1264-1271.
2. Cartwright RD, Luten A, Young M, et al.: Role of REM sleep and dream affect in overnight mood regulation: a study of normal volunteers. Psychiatry Res 1998, 81:1-8.
3. Steriade M, Timofeev I: Neuronal plasticity in thalamo-cortical networks during sleep and waking oscillations. Neuron 2003, 37:563-576.
4. Stickgold R, Hobson JA, Fosse R, Fosse M: Sleep, learning, and dreams: off-line memory reprocessing. Science 2001, 294:1052-1057.
5. Mallon L, Broman JE, Hetta J: Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med 2002, 251:207-216.
6. Meisinger C, Heier M, Loewel H: Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005, 48:235-241.
7. Mikkelsson M, Sourander A, Salminen JJ, et al.: Widespread pain and neck pain in schoolchildren. A prospective one-year follow-up study. Acta Paediatr 1999, 88:1119-1124.
8. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996, 39:411-418.
9. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
10. Irwin M, McClintick J, Costlow C, et al.: Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 1996, 10:643-653.
11. Vgontzas AN, Zoumakis E, Bixler EO, et al.: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004, 89:2119-2126.
12. Smith MT, Haythornthwaite JA: How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004, 8:119-132.
13. Perlis ML, Merica H, Smith MT, Giles DE: Beta EEG in insomnia. Sleep Med Rev 2001, 5:363-374.
14. American Academy of Sleep Medicine: The International Classification of Sleep Disorders: Diagnostic and Coding Manual, edn 2. Westchester, IL: American Academy of Sleep Medicine; 2005.
15. Drewes AM, Nielsen KD, Hansen B, et al.: A longitudinal study of clinical symptoms and sleep parameters in rheumatoid arthritis. Rheumatology (Oxford) 2000, 39:1287-1289.
16. Smith MT, Wegener ST, eds: Sleep disturbances in rheumatic diseases. In Clinical Care in the Rheumatic Diseases, edn 3. Atlanta, GA: Association of Rheumatology Health Professionals Publications; 2006:289-298.
17. Bliwise DL: Normal aging. In Principles and Practice of Sleep Medicine. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: Elsevier; 2006:24-38.
18. Haas DC, Foster GL, Nieto FJ, et al.: Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005, 111:614-621.
19. Hornyak M, Trenkwalder C: Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res 2004, 56:543-548.
20. Leigh TJ, Bird HA, Hindmarch I, Wright V: A comparison of sleep in rheumatic and non-rheumatic patients. Clin Exp Rheumatol 1987, 5:363-365.
21. Moldofsky H: Sleep and fibrositis syndrome. Rheum Dis Clin North Am 1989, 15:91-103.
22. Jennum P, Drewes AM, Andreasen A, Nielsen KD: Sleep and other symptoms in primary fibromyalgia and in healthy controls. J Rheumatol 1993, 20:1756-1759.
23. Affleck G, Urrows S, Tennen H, et al.: Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996, 68:363-368.
24. Horne J, Shackell B: Alpha-like EEG activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome. Electroencephalogr Clin Neurophysiol 1991, 79:271-276.
25. Branco J, Atalaia A, Paiva T: Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994, 21:1113-1117.
26. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA: The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007, 30:494-505.
27. Hirsch M, Carlander B, Verge M, et al.: Objective and subjective sleep disturbances in patients with rheumatoid arthritis. Arthritis Rheum 1994, 37:41-49.
28. Drewes AM, Svendsen L, Taagholt SJ, et al.: Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998, 37:71-81.
29. Drossaers-Bakker KW, Hamburger HL, Bongartz EB, et al.: Sleep apnoea caused by rheumatoid arthritis. Br J Rheumatol 1998, 37:889-894.
30. Trenkwalder C, Paulus W, Walters AS: The restless legs syndrome. Lancet Neurol 2005, 4:465-475.
31. Salih AM, Gray RE, Mills KR, Webley M: A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 1994, 33:60-63.
32. Leigh TJ, Bird HA, Hindmarch I, Wright V: A comparison of sleep in rheumatic and non-rheumatic patients. Clin Exp Rheumatol 1987, 5:363-365.
33. Wilcox S, Brenes GA, Levine D, et al.: Factors related to sleep disturbance in older adults experiencing knee pain or knee pain with radiographic evidence of knee osteoarthritis. J Am Geriatr Soc 2000, 48:1241-1251.
34. Fielden JM, Gander PH, Horne JG, et al.: An assessment of sleep disturbance in patients before and after total hip arthroplasty. J Arthroplasty 2003, 18:371-376.
35. Doherty M, Smith J: Elusive 'alpha-delta' sleep in fibromyalgia and osteoarthritis. Ann Rheum Dis 1993, 52:245.
36. Harrison MM, Childs A, Carson PE: Incidence of undiagnosed sleep apnea in patients scheduled for elective total joint arthroplasty. J Arthroplasty 2003, 18:1044-1047.
37. Tishler M, Barak Y, Paran D, Yaron M: Sleep disturbances, fibromyalgia and primary Sjogren's syndrome. Clin Exp Rheumatol 1997, 15:71-74.
38. Ward MM: Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999, 12:247-255.
39. Costa DD, Bernatsky S, Dritsa M, et al.: Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 2005, 53:272-278.
40. Gudbjornsson B, Hetta J: Sleep disturbances in patients with systemic lupus erythematosus: a questionnaire-based study. Clin Exp Rheumatol 2001, 19:509-514.
41. Smith MT, Wegener ST: Measures of sleep. Arthritis Care Res 2003, 49(Suppl 5):S184-S196.
42. Goldenberg DL, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA 2004, 292:2388-2395.
43. Bootzin RR: Stimulus control treatment for insomnia. Proceedings of the 80th Annual Convention of the APA. 1972:395-396.
44. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep 1987, 10:45-56.
45. Harvey AG, Payne S: The management of unwanted pre-sleep thoughts in insomnia: distraction with imagery versus general distraction. Behav Res Ther 2002, 40:267-277.
46. Morgenthaler T, Kramer M, Alessi C, et al.: Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 2006, 29:1415-1419.
47. Edinger JD, Wohlgemuth WK, Radtke RA, et al.: Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA 2001, 285:1856-1864.
48. Smith MT, Perlis ML, Park A, et al.: Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002, 159:5-11.
49. Irwin M, Cole JC, Nicassio PM: Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in adults and in older adults 55+ years. Health Psychol 2006, 25:3-14.
50. Smith MT, Huang MI, Manber R: Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 2005, 25:559-592.
51. Currie SR, Wilson KG, Pontefract AJ, deLaplante L: Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000, 68:407-416.
52. Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR: Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005, 165:2527-2535.
53. Smith MT, Perlis ML: Who is a candidate for cognitive-behavioral therapy for insomnia? Health Psychol 2006, 25:15-19.
54. Morin CM, Colecchi C, Stone J, et al.: Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999, 281:991-999.
55. Moldofsky H, Lue FA, Mously C, et al.: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996, 23:529-533.
56. Krystal AD, Walsh JK, Laska E, et al.: Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003, 26:793-799.
57. NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. NIH Consens Sci Statements 2005, 22:1-30.
58. Allain H, Bentue-Ferrer D, Polard E, et al.: Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005, 22:749-765.
59. Arnold LM, Keck PE Jr, Welge JA: Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000, 41:104-113.
60. O'Malley PG, Balden E, Tomkins G, et al.: Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 2000, 15:659-666.
61. Carette S, Bell MJ, Reynolds WJ, et al.: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994, 37:32-40.
62. Goldenberg D, Mayskiy M, Mossey C, et al.: A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996, 39:1852-1859.
63. Koh WH, Pande I, Samuels A, et al.: Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol 1997, 24:2158-2161.
64. Scharf MB, Baumann M, Berkowitz DV: The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003, 30:1070-1074.
65. Klerman EB, Goldenberg DL, Brown EN, et al.: Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 2001, 86:1034-1039.
66. Acuna-Castroviejo D, Escames G, Reiter RJ: Melatonin therapy in fibromyalgia. J Pineal Res 2006, 40:98-99.
67. Citera G, Arias MA, Maldonado-Cocco JA, et al.: The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000, 19:9-13.
68. Shavali S, Ho B, Govitrapong P, et al.: Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005, 64:471-479.
69. Vallieres A, Morin CM, Guay B: Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. Behav Res Ther 2005, 43:1611-1630.